PrEP awareness and decision-making for Latino MSM in San Antonio, Texas
- PMID: 28953905
- PMCID: PMC5617149
- DOI: 10.1371/journal.pone.0184014
PrEP awareness and decision-making for Latino MSM in San Antonio, Texas
Abstract
Pre-Exposure Prophylaxis (PrEP) has been promoted among high-risk populations as an effective HIV biomedical intervention. However, limited research is available on the significance of culturally informed biomedical interventions for Latino MSM. A total of 159 self-administered Internet surveys were completed by Latino MSM ages 21-30 in San Antonio, Texas. The purpose of this research was to develop an instrument that measured Latino MSM attitudes and beliefs towards PrEP, identify associations between demographic factors and PrEP related factors and to suggest culturally appropriate strategies for the promotion of PrEP among the Latino MSM population. Research findings revealed implications for PrEP at the structural and individual level for Latino MSM. Structural level indicators emphasized the importance for raising PrEP awareness among Latino MSM in regards to PrEP related expenses, ameliorating stigmatization of high-risk populations, enhancing access to PrEP informed medical providers, and address mistrust of the government and medical providers role on addressing health disparities among Latino MSM. Overall, the findings for individual factors emphasize the need for patient-centered interventions for Latino MSM. Latino MSM currently on PrEP require supplemental resources to enhance PrEP adherence. Latino MSM not on PrEP require alternate options for PrEP delivery and/or cognitive behavioral approaches minimizing HIV risk behavior for Latino MSM concerned with PrEP toxicity, which may require non-biomedical interventions. Integration of Latino MSM currently on PrEP as peer educators provides a valuable resource for developing culturally informed PrEP interventions for Latino MSM. Peer educators are able to share their experiential knowledge of PrEP contextualized through cultural norms, beliefs, and values.
Conflict of interest statement
Figures





References
-
- FDA. FDA approves first drug for reducing the risk of sexually acquired HIV infection. 2012 [Available from: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm312210.htm.
-
- CDC. Pre-Exposure Prophylaxis (PrEP). 2016 [Available from: http://www.cdc.gov/hiv/risk/prep/.
-
- CDC. CDC's New High-Impact Approach to HIV Prevention Funding for Health Departments Advancing the National HIV/AIDS Strategy. 2014 [Available from: http://www.cdc.gov/hiv/funding/announcements/ps12-1201/factsheet.html.
-
- Liu AY, Kittredge PV, Vittinghoff E, Raymond HF, Ahrens K, Matheson T, et al. Limited knowledge and use of HIV post-and pre-exposure prophylaxis among gay and bisexual men. Journal of Acquired Immune Deficiency Syndromes. 2008;47(2):241–7. - PubMed
-
- Mimiaga MJ, Case P, Johnson CV, Safren SA, Mayer KH. Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education. Journal of Acquired Immune Deficiency Syndromes. 1999;50(1). - PMC - PubMed
MeSH terms
LinkOut - more resources
Medical
Miscellaneous